Tenax Therapeutics(TENX)
CHAPEL HILL, NC
BiotechnologyFocus: Small Molecules
Tenax Therapeutics is a life sciences company focused on Small Molecules.
Cardiovascular
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Levosimendan
Heart DecompensationClinical Trials (1)
NCT02973620Levosimendan Compassionate Use in Pediatric Patients With Advanced Decompensated Heart Failure
N/ALevosimendan 2.5 mg/ml Injectable Solution
Hypertension Pulmonary Secondary Heart FailureClinical Trials (1)
NCT03624010Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients
Phase 2Oxycyte
Traumatic Brain InjuryClinical Trials (1)
NCT00908063Safety and Tolerability of Oxycyte in Patients With Traumatic Brain Injury (TBI)
Phase 2Oxycyte
Traumatic Brain InjuryClinical Trials (1)
NCT00174980Study of Oxycyte in Severe Closed Head Injury
Phase 2Levosimendan
Hypertension Pulmonary SecondaryClinical Trials (1)
NCT03541603Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF
Phase 2Phase 3
Clinical Trials (1)
NCT07288398LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Phase 3Levosimendan
Coronary Artery Bypass GraftingClinical Trials (1)
NCT02025621Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass
Phase 3TNX-103
Pulmonary HypertensionClinical Trials (1)
NCT05983250LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Phase 3Phase 3
Clinical Trials (1)
NCT07436689Long-Term Open-Label Extension Study of Oral Levosimendan
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2024
Portfolio: 9 clinical trials
SEC Filings: 2 available